In the US, pharma specialist Cutting Edge Information has launched a customized survey offering, adding to its existing proprietary databases of market data, industry executives and physicians. More
US pharma business intelligence firm Cutting Edge Information has launched a new customized survey service which taps into its database of 350,000 executives at more than 4,000 life sciences companies worldwide. More
Pharmaceutical companies are turning to MR departments to help them run leaner organizations in troubled economic times, according to a new report from sector specialist Cutting Edge Information. More
Pharma companies are moving away from the idea of hard ROI measurement for their market research, according to a study by US-based Cutting Edge Information. 74% of surveyed companies do not attempt to calculate ROI for MR. More
The world's pharmaceutical companies have been hiring market researchers at a rapid rate in the last year, according to a report from sector specialist Cutting Edge Information. Overall MR headcount is reportedly up an average of 21%. More
Pharmaceutical companies have decreased their US MR budgets by an average of 22.7% since last year, but increased them elsewhere in the world, according to a new study by Cutting Edge Information. More
Blockbuster pharmaceutical brands receive an average marketing investment of $11.7m between Pre-Clinical and Phase II – and market research dominates early phase spending, according to a report by business intelligence firm Cutting Edge Information. More
A new study from business research firm Cutting Edge Information reveals that top pharmaceutical companies start conducting MR an average of 6.2 years before a drug launch. The study highlights the research strategies and techniques of leading drugs companies. More
Pharmaceutical companies may be starving the next generation of blockbuster drugs of the development support they need, according to a study by business intelligence firm Cutting Edge Information. More than $100bn worth of products face patent expiration over the next three years, says the study. More
Major pharmaceutical companies typically spend around $3 - 4 million on pre-launch research for a product, and spend an average of $710,000 on post-launch or 'in-line' product research, according to a new report from US pharmaceutical intelligence firm Cutting Edge Information. More
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online